Table 2.

Serum levels of SAA in LTX patients (* = groups of patients in the study where the high levels of SAA are statistically significant)

LTX AR*	115.60 ± 38.04 µg/ml
LTX CLAD	109.37 ± 56.04 µg/ml
LTX INF*	127.89 ± 38.88 µg/ml
LTX NEG	76.84 ± 39.06 µg/ml
CONTROLS	43.02 ± 25.18 µg/ml